Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRLAB Therapeutics Director's Dealing 2023

Mar 7, 2023

3062_iss_2023-03-07_096fc1ac-1204-4663-89af-7a45ecb329c2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Issuer IRLAB Therapeutics AB

Holder

196804 Daniel Johnsson

Instrument

Instrument Aktie SE0012675361
Before the transaction
Shares 2,690,000
Voting rights 2,690,000
Transaction
Date 07/03/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 4,500,000
Directly held voting rights 4,500,000
Indirectly held voting rights 0

Percentage

Directly held shares 8.66 % Directly held voting rights 8.66 % Indirectly held voting rights 0 %

Resulting distribution of total

holdings
Percentage of voting
rights:
Number of underlying
shares:
Shares 8.66 % 4,500,000
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 8.66 % 4,500,000
Group total holdings
Voting rights
4,500,000
Percentage of voting rights 8.66
Published
07/03/2023 22:34
Contact
Name
Daniel Johnsson
Phone
+46736876400 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25